Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH80949D
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The university spans its expertise in cancer research, neuroscience and neurodegenerative diseases, diabetes, stem cell therapy, epidemiology, Middle Eastern studies, materials science, and nanotechnology among others. It works in collaboration with other universities through international networks, cooperation platforms for research and education. LNU is headquartered in Lund, Sweden.

Lund University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Lund University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Lund University, Medical Devices Deals, 2012 to YTD 2018 10

Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Lund University, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

RhoVac Enters into Research Agreement with Lund University 12

Rocket Pharma Entered into Research and Development Agreement with Lund University 13

Licensing Agreements 14

Novo Nordisk Enters into Research and Licensing Agreement with Lund University 14

Avrobio Enters into Licensing Agreement with Lund University 15

Equity Offering 16

Akuru Pharma Spin Out from Lund University 16

Lund University-Key Competitors 17

Lund University-Key Employees 18

Lund University-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Joint Venture 20

Recent Developments 21

Government and Public Interest 21

Oct 08, 2018: New discovery restores insulin cell function in type 2 diabetes 21

Oct 05, 2018: New function of a key component in the immune system discovered 24

Oct 05, 2018: Large grants awarded to research on brain repair and diatoms 25

Sep 26, 2018: Researchers devise new approach to target Alzheimer's 27

Aug 29, 2018: Lund University research group receives follow-on DKK 1 million grant from Novo Nordisk Foundation for diabetes-related studies with Follicum peptides 28

Aug 22, 2018: New method grows brain cells from stem cells quickly and efficiently 29

Aug 21, 2018: Powerful molecules provide new findings about Huntington's disease 31

Apr 18, 2018: Similarity between high-risk atherosclerotic plaque and cancer cells discovered 33

Apr 16, 2018: Hope for new treatment of severe epilepsy 34

Apr 09, 2018: Jan Sundquist at Lund University awarded an ERC Advanced Grant 35

Apr 06, 2018: Mechanism vital to keeping blood stem cells functional uncovered 36

Apr 03, 2018: Breakthrough for dangerous blood transfusion-related disease 37

Mar 02, 2018: Paradigm shift in the diagnosis of diabetes 38

Nov 30, 2017: Prestigious ERC grants awarded to Lund researchers 40

Nov 28, 2017: Molecular profiling of melanoma tumours explains differences in survival after T cell therapy 42

Nov 06, 2017: Helmsley Charitable Trust Awards USD 52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 44

Nov 02, 2017: New research shows where in the brain the earliest signs of Alzheimers occur 46

Oct 25, 2017: New method helps rule out heart valve infection 48

Oct 05, 2017: Discovery of a new fusion gene class may affect the development of cancer 49

Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 50

Jan 30, 2017: Unique mapping of methylome in insulin-producing islets 54

Product News 55

Jun 25, 2018: Fluorescent molecules reveal how cancer stem cells are selectively inhibited 55

May 29, 2017: New test method aims to predict allergenic potency of chemicals 56

Mar 12, 2018: New treatment for aggressive breast cancer 57

Mar 12, 2018: Aggressive breast cancer can be transformed into a treatable form 58

Other Significant Developments 59

Feb 06, 2017: An Innovative Medicines Initiative Project for Precision Medicine in DKD 59

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

Lund University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Lund University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Lund University, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Lund University, Pharmaceuticals & Healthcare, Key Facts 2

Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Lund University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Lund University, Deals By Therapy Area, 2012 to YTD 2018 9

Lund University, Medical Devices Deals, 2012 to YTD 2018 10

Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

RhoVac Enters into Research Agreement with Lund University 12

Rocket Pharma Entered into Research and Development Agreement with Lund University 13

Novo Nordisk Enters into Research and Licensing Agreement with Lund University 14

Avrobio Enters into Licensing Agreement with Lund University 15

Akuru Pharma Spin Out from Lund University 16

Lund University, Key Competitors 17

Lund University, Key Employees 18

Lund University, Other Locations 19

Lund University, Subsidiaries 19

Lund University, Joint Venture 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Lund University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17840
Site License
USD 500 INR 35680
Corporate User License
USD 750 INR 53520

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com